Literature DB >> 35741185

A New Methodology to Assess Fallopian Tubes Microbiota and Its Impact on Female Fertility.

Salvatore Giovanni Vitale1, Jose Carugno2, Maurizio Nicola D'Alterio3, Mislav Mikuš4, Pasquale Patrizio2, Stefano Angioni3.   

Abstract

Tubal factor is an important contributor to female infertility, and the current diagnostic approaches cannot correctly identify many subtle causes of tubal dysfunction. While it is known that the most common cause of tubal factor infertility is pelvic inflammatory disease (PID), creating critical alterations of the tubal epithelium, little attention has been devoted to understanding the tubal modifications caused by the resident microbial population and their interaction with the surrounding tubal epithelium. Furthermore, most of these samples are obtained by traumatic procedures such as direct sampling during laparoscopy using a cytobrush. However, as in any other organ of the female genital tract, the microbiota environment of the fallopian tube plays an essential role in maintaining tubal functioning, counteracting the pathogenic effect of acquired microbes. Consequentially, to better analyze the tubal microbiota without causing anatomical and/or functional alteration of the fallopian tube and preserving fertility, the hysteroscopic approach might be the method of choice, guarantying maximal integrity of the uterine cavity and tubal lumen. Here we describe our plan for using atraumatic hysteroscopic sampling methods to investigate the correlation between tubal microbiota and female infertility.

Entities:  

Keywords:  female infertility; hysteroscopy; laparoscopy; pelvic inflammatory disease (PID); tubal microbiota

Year:  2022        PMID: 35741185      PMCID: PMC9221911          DOI: 10.3390/diagnostics12061375

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


Tubal factor causes 30% of all female infertility and generally occurs secondary to tubal obstruction, distortion, or intrinsic dysfunction of the epithelium [1]. The most prevalent cause of tubal factor infertility is pelvic inflammatory disease (PID) which is caused by several pathogens. PID affects tubal patency not only with macroscopic structural distortions [2] but also by affecting the tubal epithelium directly [3,4]. Various cytological studies demonstrated that several PID pathogens (Chlamydia trachomatis, Neisseria gonorrhoeae, Escherichia coli, Mycoplasma hominis, Mobiluncus, Bacteroides and Ureolyticus) cause ultrastructural changes consisting of sloughing and/or destroying of ciliated cells, with subsequent cessation of ciliary activity, disruption of cell junctions and apoptosis of epithelial cells. These are the consequences of several pathogenic mechanisms such as direct cytotoxic effect, immune response, secretion of chemokines, and cytokines [5,6]. Several studies have confirmed that each organ of the female genital tract is characterized by the presence of a specific microbial population that plays a pivotal role in maintaining the normal reproductive function, and preventing dismicrobisms and infections [7,8]. Similar to what happens in the vagina and the endometrium, it could be argued that the microbiota, as a result of a delicate balance of the all-female genital tract organs, also plays a prominent role in the tubal function and, therefore, in female fertility opposing to pathogenic microbes. With this in mind, a few authors have focused their efforts on the direct evaluation of microbe’s effect on the tubal lumen, assessing, incidentally, only the detection of the most common pathogens. The majority of data currently available in the literature come from studies obtained by laparoscopic access, specifically by salpingectomy [9]. Other samples were retrieved by direct biopsies of the distal portion of the fallopian tube during laparoscopic procedures [10]. It is important to consider that surgical excision of the Fallopian tubes represents a methodological bias for microbes and cytological sampling for several reasons. First, mechanical manipulation and electrocoagulation may impair the microbiological and cytological content. Second, the salpingectomy reduces the analysis area to a restricted portion of the fallopian tube without considering the microbes present in the entire tubal lumen. Furthermore, tubal microbiota results from a dynamic steadiness derived from the anatomical and functional integrity of the whole internal female genital tract. Thus salpingectomy, interrupting this integrity, might interfere with this delicate balance. To maintain the anatomical and functional integrity of the whole female genital tract and obtain a cytological and microbiological sample of the tubal epithelium, finding a non-invasive technique becomes mandatory. In this perspective, the hysteroscopic approach could be the method of choice for an indirect tubal integrity evaluation (cytological and microbiological). Currently, hysteroscopy is considered the ideal diagnostic procedure for assessing the vaginal walls, cervical canal, uterine cavity, endometrium, and tubal ostia [11,12,13]. Moreover, hysteroscopy could be performed in an office setting without the need for anaesthesia, using modern miniaturized hysteroscopes equipped with a 5 French operative channel, ensuring the direct vision of the structures without compromising their integrity [14]. Some authors have used the hysteroscope to obtain fallopian tissue samples to determine the etiologic diagnosis of salpingitis using a cytobrush inserted through the working channel [15]. The hysteroscopic approach seems more appropriate than the laparoscopic approach because of its less invasiveness and lower cost. However, the use of cytobrush has some critical implications worth highlighting. First, the unavoidable mechanical trauma caused by the cytobrush may irreversibly damage the fallopian tube epithelium, causing iatrogenic tubal lesions and potentially impacting future fertility. Furthermore, the diameter and the limited flexibility of the cytobrush make this device inadequate for the microbiological and cytological sampling of the distal tubal lumen. Although hysteroscopy seems the most appropriate minimally invasive method to examine the tubal factor, scanty and inconsistent data are currently available in the literature to support its use. In conclusion, the tubal infertility factors remain an enigmatic dilemma waiting to be discovered entirely, and the microbiota, with its changes, could be a milestone in the understanding of tubal factor infertility. Although vaginal and endometrial microbiota are extensively studied in the literature [7,8], scant evidence can be gathered regarding tubal microbiota [16]. Consequentially, understanding the tubal microbiota in relation to some demographic variables such as ethnicity, parity, and history of infertility could be relevant to understanding the role of these microbes in maintaining the tubal patency. For this purpose, alternative microbiological and cytological sampling methods should be encouraged without the potential methodological bias described above. Thus, large multicentre well-designed studies using hysteroscopic sampling methods are necessary to elucidate the relationship between tubal microbiota and female infertility.
  15 in total

1.  Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients.

Authors:  T Haahr; J S Jensen; L Thomsen; L Duus; K Rygaard; P Humaidan
Journal:  Hum Reprod       Date:  2016-02-23       Impact factor: 6.918

Review 2.  Endometrial microbiota-new player in town.

Authors:  Inmaculada Moreno; Jason M Franasiak
Journal:  Fertil Steril       Date:  2017-06-14       Impact factor: 7.329

3.  Studies of ciliated epithelia of the human genital tract. 3: Mucociliary wave activity in organ cultures of human Fallopian tubes challenged with Neisseria gonorrhoeae and gonococcal endotoxin.

Authors:  P A Mårdh; B Baldetorp; C H Håkansson; H Fritz; L Weström
Journal:  Br J Vener Dis       Date:  1979-08

4.  Office vaginoscopic hysteroscopy in infertile women: effects of gynecologist experience, instrument size, and distention medium on patient discomfort.

Authors:  Nicola Pluchino; Filippo Ninni; Stefano Angioni; Paolo Artini; Viana Gersia Araujo; Gabriele Massimetti; A R Genazzani; Vito Cela
Journal:  J Minim Invasive Gynecol       Date:  2010 May-Jun       Impact factor: 4.137

5.  Fallopian tissue sampling with a cytobrush during hysteroscopy: a new approach for detecting tubal infection.

Authors:  G Haeusler; C Tempfer; R Lehner; C Sam; C Kainz
Journal:  Fertil Steril       Date:  1997-03       Impact factor: 7.329

6.  Pregnancy outcome after hysteroscopic myomectomy.

Authors:  Pietro Litta; Lorena Conte; Francesca De Marchi; Carlo Saccardi; Stefano Angioni
Journal:  Gynecol Endocrinol       Date:  2013-12-05       Impact factor: 2.260

7.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

8.  Association between antibody to the chlamydial heat-shock protein and tubal infertility.

Authors:  B Toye; C Laferrière; P Claman; P Jessamine; R Peeling
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

Review 9.  Current management of tubal infertility: from hysterosalpingography to ultrasonography and surgery.

Authors:  I Briceag; A Costache; V L Purcarea; R Cergan; M Dumitru; I Briceag; M Sajin; A T Ispas
Journal:  J Med Life       Date:  2015 Apr-Jun

10.  The Role of Genital Tract Microbiome in Fertility: A Systematic Review.

Authors:  Salvatore Giovanni Vitale; Federico Ferrari; Michał Ciebiera; Magdalena Zgliczyńska; Agnese Maria Chiara Rapisarda; Giada Maria Vecchio; Alessandra Pino; Giuseppe Angelico; Anna Knafel; Gaetano Riemma; Pasquale De Franciscis; Stefano Cianci
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

View more
  1 in total

1.  Technical Tips and Tricks after 10 Years of HyFoSy for Tubal Patency Testing.

Authors:  Roxana-Elena Bohîlțea; Bianca-Margareta Mihai; Cătălina-Diana Stănică; Consuela-Mădălina Gheorghe; Costin Berceanu; Vlad Dima; Alexia-Teodora Bohîlțea; Smaranda Neagu; Radu Vlădăreanu
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.